Iodine Supplementation and Fertility Parameters

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorTehran University of Medical Sciences

About this trial

Iodine has been identified as a potential factor influencing female fertility during the childbearing years. The American Thyroid Association recommends that women attempting to conceive take a supplement containing 150 µg of iodine. However, no clinical trials have specifically examined the necessity of iodine supplementation in women experiencing infertility. Furthermore, no information is available on the optimal dose and duration of iodine supplementation to increase the chances of successful treatment in this group of women. Therefore, this study aims to investigate the effects of iodine supplementation on fertility parameters in infertile women.

Eligibility criteria

Qualifiers

Women with diminished ovarian reserve

Willingness to participate

Age range: 18 to 45 years

Women with a menstrual cycle of 21 to 42 days

Disqualifiers

Unwillingness to participate

Women with polycystic ovary syndrome or endometriosis

Diagnosis of any thyroid disease

Use of any medication that affects the thyroid function

Trial design

Treatments tested in this trial

  • Iodine
  • Placebo

Treatment groups

230 Participants
are divided into 2 treatment groups

Locations

This trial has no locations